A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus
- PMID: 2983194
- PMCID: PMC366725
- DOI: 10.1128/mcb.5.2.410-413.1985
A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus
Abstract
Epstein-Barr virus (EBV) transforms human B-lymphocytes into proliferating blasts which are efficiently established into cell lines. The viral DNA in these cell lines is usually present as complete, unintegrated plasmid molecules. A cis-acting element of EBV, oriP, permits plasmid maintenance in adherent cells that carry EBV DNA. We constructed a vector, pHEBo, that carries oriP and showed that it is also efficiently maintained as a plasmid when introduced into EBV-transformed B-lymphoblasts. The pHEBo vector carries the coding sequences for the hph gene from Escherichia coli such that it can be expressed in mammalian cells and confers resistance to the antibiotic hygromycin B. Hygromycin B kills EBV-transformed lymphoblasts at concentrations of 50 to 300 micrograms/ml. The combination of oriP plus the expressed hph gene makes pHEBo useful for the stable introduction of genes on plasmids into EBV-transformed lymphoblasts. Because pHEBo is derived from the plasmid pBR322 it can be easily isolated from lymphoblasts by reintroduction into E. coli.
Similar articles
-
Transforming functions associated with Epstein-Barr virus.J Invest Dermatol. 1984 Jul;83(1 Suppl):82s-87s. doi: 10.1111/1523-1747.ep12281491. J Invest Dermatol. 1984. PMID: 6330229 Review.
-
Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells.Gene. 1989 Dec 14;84(2):407-17. doi: 10.1016/0378-1119(89)90515-5. Gene. 1989. PMID: 2482230
-
Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis.Mol Biol Med. 1988 Apr;5(2):85-94. Mol Biol Med. 1988. PMID: 2840551
-
Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication.J Virol. 1989 Jul;63(7):3016-25. doi: 10.1128/JVI.63.7.3016-3025.1989. J Virol. 1989. PMID: 2542609 Free PMC article.
-
Immortalizing genes of Epstein-Barr virus.Adv Virus Res. 1991;40:19-55. doi: 10.1016/s0065-3527(08)60276-6. Adv Virus Res. 1991. PMID: 1659776 Review.
Cited by
-
Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector.EMBO J. 1987 Feb;6(2):355-61. doi: 10.1002/j.1460-2075.1987.tb04762.x. EMBO J. 1987. PMID: 3034585 Free PMC article.
-
The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes.EMBO J. 1990 Dec;9(13):4425-33. doi: 10.1002/j.1460-2075.1990.tb07893.x. EMBO J. 1990. PMID: 1702384 Free PMC article.
-
A novel BK virus-based episomal vector for expression of foreign genes in mammalian cells.Nucleic Acids Res. 1991 Apr 25;19(8):1925-31. doi: 10.1093/nar/19.8.1925. Nucleic Acids Res. 1991. PMID: 1709496 Free PMC article.
-
EBNA1 distorts oriP, the Epstein-Barr virus latent replication origin.J Virol. 1992 Mar;66(3):1786-90. doi: 10.1128/JVI.66.3.1786-1790.1992. J Virol. 1992. PMID: 1310782 Free PMC article.
-
Stable integration of mouse DNA into Ia-negative human B-lymphoma cells causes reexpression of the human Ia-positive phenotype.Proc Natl Acad Sci U S A. 1986 Oct;83(19):7415-8. doi: 10.1073/pnas.83.19.7415. Proc Natl Acad Sci U S A. 1986. PMID: 3489937 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources